GILD vs NVST · P/E 18, rev $7.80B vs P/E 56, rev $1.44B
Gilead Sciences Inc (GILD) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the GILD and NVST stock pages for the full models.
Not investment advice.